SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Since Jun 07, 2012, SUPERNUS PHARMACEUTICALS, INC. (SUPN) has reported earnings 59 times. On average the shares move ±5.32% post-earnings, with a positive reaction 59.3% of the time. Its largest post-earnings gain was +14.49% (Aug 06, 2024) and its largest decline was -19.71% (Mar 14, 2013). The next earnings report is predicted for 2026-11-11 (approximate).
Earnings reactions
How SUPN moved on each past earnings report.
Earnings Impact
Total Earnings
59
Avg Abs. Movement
±5.32%
Positive %
59.3%
Negative %
40.7%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 03, 2026 | ☀ PRE | +3.06% | open_in_new |
| Jul 22, 2026 | ☽ POST | +0.51% | open_in_new |
| May 05, 2026 | ☽ POST | +4.6% | open_in_new |
| Apr 22, 2026 | ☽ POST | +0.2% | open_in_new |
Earnings Count
59
Total earnings in dataset
Avg Abs. Movement
±5.32%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260814 | open_in_new SEC.gov |
| 4 | 20260814 | open_in_new SEC.gov |
| 4 | 20260814 | open_in_new SEC.gov |
| 4 | 20260814 | open_in_new SEC.gov |
| 4 | 20260814 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260806 | open_in_new SEC.gov |
| 425 | 20260804 | open_in_new SEC.gov |
| 10-Q | 20260803 | open_in_new SEC.gov |
| 425 | 20260803 | open_in_new SEC.gov |
| 425 | 20260803 | open_in_new SEC.gov |
Frequently asked about SUPN earnings
When does SUPERNUS PHARMACEUTICALS, INC. report earnings next? expand_more
SUPERNUS PHARMACEUTICALS, INC. (SUPN)'s next earnings date is approximate for 2026-11-11. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does SUPN stock move after earnings? expand_more
Over 59 reports, SUPN has moved an average of ±5.32% the session after earnings, closing higher 59.3% of the time.
What was SUPN's biggest post-earnings move? expand_more
SUPN's largest post-earnings gain on record was +14.49% on Aug 06, 2024, and its largest decline was -19.71% on Mar 14, 2013.
Where can I find SUPERNUS PHARMACEUTICALS, INC.'s SEC filings? expand_more
All of SUPERNUS PHARMACEUTICALS, INC.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right